Lotus Eye Hospital and Institute peers

Companies like Lotus Eye Hospital and Institutelatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

LOTUSEYE₹110.00

Lotus Eye Hospital and Institute Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹229 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
LOTUSEYE
FY26
GPTHEALTH
FY26
GKSL
FY26
SHALBY
FY26
Peer
Average
Valuation — at last close
P/E2750.00×◆ 26.58×69.02×37.76×44.45× +6086%
P/B3.80×4.17×5.37×◆ 1.30×3.61× +5%
EV/EBITDA69.87×12.97×48.88×◆ 12.38×24.74× +182%
Market Cap₹229 Cr₹1,123 Cr₹1,355 Cr₹1,311 Cr₹1,263 Cr -82%
Growth
Revenue CAGR 3Y4.52%——◆ 12.35%12.35% -63%
Revenue CAGR 5Y10.66%————
Net Income CAGR 3Y-72.98%——◆ -19.97%-19.97% -265%
Revenue YoY (latest Q)◆ 26.19%17.83%—11.74%14.79% +77%
Net Income YoY (latest Q)12.65%◆ 65.73%—36.70%51.22% -75%
Profitability
EBITDA Margin6.30%17.81%◆ 32.85%12.51%21.06% -70%
Net Income Margin0.15%8.93%◆ 20.50%3.04%10.82% -99%
Return on Common Equity0.13%◆ 16.32%6.14%3.74%8.73% -99%
Return on Capital Employed-0.54%◆ 16.42%8.24%5.79%10.15% -105%
Return on Assets0.11%◆ 9.95%5.65%1.96%5.85% -98%
Credit & Quality
Total Debt/Equity0.19×◆ 0.06×0.06×0.54×0.22× -14%
Interest Coverage-0.43×6.93×◆ 11.84×1.87×6.88× -106%
Scale — latest FY
Revenue / Total Income₹53.7 Cr₹473 Cr₹82 Cr₹1,141 Cr₹565 Cr -90%
Net Income₹0.1 Cr₹42.2 Cr₹16.8 Cr₹34.7 Cr₹31.2 Cr -100%
Total Assets₹82.6 Cr₹465 Cr₹298 Cr₹1,839 Cr₹867 Cr -90%
EPS₹0.04₹5.15₹2.49₹3.23₹3.62 -99%
Book Value per Share₹28.92₹32.84₹32.03₹93.49₹52.79 -45%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.